Inventor · disambiguated record
Tsutomu Kurokawa
Also filed as: KUROKAWA TSUTOMU
11 granted patents·256 citations·filing 1989–1998
92Inventor score
Files withTAKEDA CHEMICAL INDUSTRIES LTD11
Top patents by PatentIndex Score
11 records- 0189US5712100AAntibodies to peptides having NGF-like activity, and use thereofTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1995·Granted Jan 27, 1998·71 cites·4 claims
- 0281US5656435AAntibodies to peptides having NGF-like activity, said antibodies having no substantial cross-reactivity with NGF, and use thereofTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1994·Granted Aug 12, 1997·45 cites·10 claims
- 0379US5512460AGlia activating factor and its productionTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1994·Granted Apr 30, 1996·40 cites·8 claims
- 0468US5622928AGlia activation factor and its productionTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1996·Granted Apr 22, 1997·25 cites·12 claims
- 0567US5571895AModified GAF polypeptidesTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1993·Granted Nov 5, 1996·38 cites·3 claims
- 0657US6221637B1Xanthene derivatives, their production and useTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1997·Granted Apr 24, 2001·7 cites·20 claims
- 0754US5858779AMonoclonal antibody, hybridoma, their production and use thereofTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1995·Granted Jan 12, 1999·7 cites·4 claims
- 0852US5852177ABasic fibroblast growth factor (bFGF) muteinsTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1989·Granted Dec 22, 1998·9 cites·13 claims
- 0945US5559093AN-terminally truncated hst-1 is a platelet-increasing factorTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1993·Granted Sep 24, 1996·7 cites·1 claims
- 1045US5478740AHybridomas and monoclonal antibodies which specifically bind human basic fibroblast growth factorTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1992·Granted Dec 26, 1995·6 cites·6 claims
- 1131US5981197AMonoclonal antibody, hybridoma, their production and use thereofTAKEDA CHEMICAL INDUSTRIES LTD·Filed 1998·Granted Nov 9, 1999·1 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Tsutomu Kurokawa files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →